0001735726-19-000003.txt : 20190422 0001735726-19-000003.hdr.sgml : 20190422 20190422132737 ACCESSION NUMBER: 0001735726-19-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190422 DATE AS OF CHANGE: 20190422 EFFECTIVENESS DATE: 20190422 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OncoNano Medicine, Inc. CENTRAL INDEX KEY: 0001735726 IRS NUMBER: 811713330 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-308806 FILM NUMBER: 19759065 BUSINESS ADDRESS: STREET 1: 550 RESERVE STREET STREET 2: SUITE 190 CITY: SOUTHLAKE STATE: TX ZIP: 76092 BUSINESS PHONE: (682) 712-1581 MAIL ADDRESS: STREET 1: 550 RESERVE STREET STREET 2: SUITE 190 CITY: SOUTHLAKE STATE: TX ZIP: 76092 D/A 1 primary_doc.xml X0708 D/A LIVE 0001735726 OncoNano Medicine, Inc. 550 Reserve Street Suite 190 Southlake TX TEXAS 76092 (682) 712-1581 DELAWARE None None Corporation true 2014 Ravi Srinivasan c/o OncoNano Medicine, Inc. 550 Reserve Street, Suite 190 Southlake TX TEXAS 76092 Executive Officer Director John Dyett c/o OncoNano Medicine, Inc. 550 Reserve Street, Suite 190 Southlake TX TEXAS 76092 Director Alvaro Guillem c/o OncoNano Medicine, Inc. 550 Reserve Street, Suite 190 Southlake TX TEXAS 76092 Director Paritosh Dhawale c/o OncoNano Medicine, Inc. 550 Reserve Street, Suite 190 Southlake TX TEXAS 76092 Director Joydeep Goswami c/o OncoNano Medicine, Inc. 550 Reserve Street, Suite 190 Southlake TX TEXAS 76092 Director Matthew Head c/o OncoNano Medicine, Inc. 550 Reserve Street, Suite 190 Southlake TX TEXAS 76092 Executive Officer Biotechnology Decline to Disclose 06b true 0001735726-18-000001 2018-03-13 false true true false 0 Salem Partners LLC 43363 None None 11111 Santa Monica Blvd., Suite 2250 Los Angeles CA CALIFORNIA 90025 AL ALABAMA AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT DE DELAWARE DC DISTRICT OF COLUMBIA FL FLORIDA GA GEORGIA HI HAWAII IL ILLINOIS IN INDIANA MD MARYLAND MA MASSACHUSETTS MI MICHIGAN MN MINNESOTA MS MISSISSIPPI MO MISSOURI NV NEVADA NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA OR OREGON PA PENNSYLVANIA TN TENNESSEE TX TEXAS UT UTAH VA VIRGINIA WA WASHINGTON WI WISCONSIN WY WYOMING false 35392140 33899361 1492779 The total offering amount includes conversion of principal and interest under outstanding promissory notes. false 39 0 600000 The broker earned: $600,000 in cash and a warrant to purchase 600,096 shares of common stock for the first $11,658,526 sold, and a 5% cash fee and warrants to purchase common stock equal to 5% of later sales, not including a $25,000 retainer. 0 false OncoNano Medicine, Inc. /s/ Ravi Srinivasan Ravi Srinivasan President and CEO 2019-04-17